stock & financial message boards
  Login  |  Register |  Site Map  |  Blogs |  Recent Activity  |  Members  | Glossary
Ticker/Industry
  Joined Today: 1

« Previous | Next » | All Messages |  NURO Message Board Home | recommend post |  Ignore Poster

Message #19
From: Stock News Bot
Date: October 11, 2006 10:00:00 AM

NURO News NeuroMetrix, Inc Announces Date for 2006 Third Quarter Financial Results Conference Call

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO) today said it plans to issue its 2006 third quarter financial results before the opening of the market on Thursday, October 26, 2006. The Company’s management team will host a conference call and webcast at 10:00 AM Eastern time, on the same day, to discuss the Company’s financial results for the third quarter ended September 30th. In addition, the Company will be available to answer questions concerning business and financial developments and trends, and other business and financial matters affecting the Company.

The conference call may be accessed in the United States by dialing 866-383-8108 and using the confirmation code 11826483. Internationally, the conference call may be accessed by dialing 617-597-5343 and using the same confirmation code. The webcast, along with the earnings press release and accompanying condensed financial statements, will be accessible from the Company’s website at www.neurometrix.com under the “Investors” tab.

A replay of the webcast will be available starting two hours after the call by dialing 888-286-8010, domestically and 617-801-6888, internationally. The confirmation code to access the replay is 17640044. The replay will be available for a period of three months following the conference call.

About NeuroMetrix

NeuroMetrix is a medical device company that is establishing a new standard of care through the design, development and sale of proprietary products used to help physicians diagnose neuropathies. Neuropathies are diseases of the peripheral nerves and parts of the spine that frequently are caused by or associated with diabetes, low back pain and carpal tunnel syndrome, as well as other clinical disorders. The NC-stat System, the Company's neuropathy diagnostic system, has been on the market since May 1999 and is presently used in over 4,000 physician's offices and clinics in the United States. The Company holds issued utility patents covering a number of important aspects of the NC-stat System.

« Previous | Next » | All Messages |  NURO Message Board Home | Ignore Poster